Heterogeneity in preferences for outcomes of integrated care for persons with multiple chronic diseases: a latent class analysis of a discrete choice experiment
Hoedemakers M. et al, (2022), Quality of Life Research
Moving Beyond Quality-Adjusted Life-Years in Elderly Care: How Can Multicriteria Decision Analysis Complement Cost-Effectiveness Analysis in Local-Level Decision Making
Hoedemakers M. et al, (2022), Value in Health
The early impact of the COVID-19 pandemic on patients with severe mental illness: An interrupted time series study in South-East England
Penington E. et al, (2022), European Psychiatry
Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients.
Tsiachristas A. et al, (2022), BMC Cancer, 22
Value-based person-centred integrated care for frail elderly living at home: a quasi-experimental evaluation using Multi-Criteria Decision Analysis
Hoedemakers M. et al, (2022), BMJ Open
The net benefit of personalised medicine: A systematic literature review and regression analysis.
Vellekoop H. et al, (2022), Value in Health
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options Article
Koleva-Kolarova R. et al, (2022), Applied Health Economics and Health Policy
Cost-effectiveness of psychosocial assessment for individuals who present to hospital following self-harm in England: a model-based retrospective analysis
McDaid D. et al, (2022), European Psychiatry, 1 - 32
Hospital at Home admission avoidance with comprehensive geriatric assessment to maintain living at home for people aged 65 years and over: a RCT
Shepperd S. et al, (2022), Health and Social Care Delivery Research, 10, 1 - 124
WHAT IS THE NET ADDED VALUE OF PERSONALISED MEDICINE? A SYSTEMATIC LITERATURE REVIEW
Vellekoop H. et al, (2022), VALUE IN HEALTH, 25, S75 - S75
Better outcomes for everybody evaluates the effectiveness and cost-effectiveness of a pharmacist-led intervention, delivered by community pharmacists in collaboration with physicians, in improving disease control, compared with usual care, in asthma and COPD patients during and after COVID-19
Manfrin A. et al, (2021), Medicine: Case Reports and Study Protocols, 2, e0158 - e0158
Appraisal of patient-level health economic models of severe mental illness: systematic review
Altunkaya J. et al, (2021), The British Journal of Psychiatry, 1 - 12
Is Comprehensive Geriatric Assessment hospital at home a cost-effective alternative to hospital admission for older people?
Singh S. et al, (2021), Age and Ageing
Real-world performance and accuracy of stress echocardiography: the EVAREST observational multi-centre study
WOODWARD W. et al, (2021), European Heart Journal: Cardiovascular Imaging
Bundled payments for chronic diseases increased health care expenditure in the Netherlands, especially for multimorbid patients
Karimi M. et al, (2021), Health Policy
Economic evaluation of new models of care: does the decision change between Cost-Utility Analysis and Multi-Criteria Decision Analysis?
van den Bogaart EHA. et al, (2021), Value in Health
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
Vellekoop H. et al, (2021), PharmacoEconomics
ECONOMIC EVALUATION OF NEW MODELS OF CARE: DOES THE DECISION CHANGE BETWEEN COST-UTILITY ANALYSIS AND MULTI-CRITERIA DECISION ANALYSIS?
van den Bogaart E. et al, (2020), VALUE IN HEALTH, 23, S650 - S650
FINANCING AND REIMBURSEMENT FOR PERSONALISED MEDICINE - ARE WE THERE YET?
Koleva-Kolarova R. et al, (2020), VALUE IN HEALTH, 23, S756 - S756